Tekla Life Sciences Investors

(NYSE:HQL)

Latest On Tekla Life Sciences Investors (HQL):

Date/Time Type Description Signal Details
2024-02-21 05:53 ESTDividendA dividend of $0.39 has been announced on Feb 9, 2024. It will be paid Mar 28, 2024 with an ex-dividend date of Feb 21, 2024.Neutral
2023-11-21 05:09 ESTDividendA dividend of $0.3 has been announced on Nov 9, 2023. It will be paid Jan 10, 2024 with an ex-dividend date of Nov 21, 2023.Neutral
2023-08-24 06:10 ESTDividendA dividend of $0.32 has been announced on Aug 15, 2023. It will be paid Sep 29, 2023 with an ex-dividend date of Aug 24, 2023.Neutral
2023-05-24 06:09 ESTDividendA dividend of $0.32 has been announced on May 15, 2023. It will be paid Jun 30, 2023 with an ex-dividend date of May 24, 2023.Neutral
2023-05-15 19:29 ESTNewsTekla Life Sciences dividend declines by 3% to $0.32N/A
2023-03-08 05:20 ESTNewsHQL: Boom-Bust Returns May Not Be Suitable For High Distribution YieldN/A
2023-02-24 05:09 ESTDividendA dividend of $0.33 has been announced on Feb 15, 2023. It will be paid Mar 31, 2023 with an ex-dividend date of Feb 24, 2023.Neutral
2023-02-15 20:19 ESTNewsTekla Life Sciences raises dividend by 6.5% to $0.33N/A
2022-12-08 20:05 ESTNewsEquity CEFs: What's Going On With Tekla's HQH And HQL?N/A
2022-11-23 05:09 ESTDividendA dividend of $0.31 has been announced on Nov 15, 2022. It will be paid Dec 30, 2022 with an ex-dividend date of Nov 23, 2022.Neutral
2022-11-16 23:28 ESTNewsTekla Life Sciences declines quarterly dividend by -11.4% to $0.31/shareN/A
2022-10-23 12:18 ESTNewsTekla Life Sciences Investors: 10% Yield And Trading 10.5% Below NAVN/A
2022-08-25 06:09 ESTDividendA dividend of $0.31 has been announced on Aug 16, 2022. It will be paid Sep 30, 2022 with an ex-dividend date of Aug 25, 2022.Neutral
2022-07-12 21:19 ESTNewsHQL: A Biotechnology Equity CEF With No LeverageN/A
2022-05-26 06:09 ESTDividendA dividend of $0.35 has been announced on May 17, 2022. It will be paid Jun 30, 2022 with an ex-dividend date of May 26, 2022.Neutral
2022-05-18 01:20 ESTNewsTekla Life Sciences cuts dividend by 10% to $0.35N/A
2022-04-27 16:56 ESTNewsHQL: Buy For The Yield, If You Can Stomach The DepreciationN/A
2022-03-22 13:37 ESTNewsTekla Capital's funds extend buyback through 2023N/A
2022-02-24 05:09 ESTDividendA dividend of $0.39 has been announced on Feb 15, 2022. It will be paid Mar 31, 2022 with an ex-dividend date of Feb 24, 2022.Neutral
2022-02-16 12:09 ESTNewsTekla Life Sciences cuts dividend by 7% to $0.39N/A
2022-02-11 14:51 ESTNewsTekla Life Sciences Investors: Buy For Steady, Quarterly DividendN/A
2021-11-23 05:09 ESTDividendA dividend of $0.42 has been announced on Nov 12, 2021. It will be paid Dec 31, 2021 with an ex-dividend date of Nov 23, 2021.Neutral
2021-11-15 18:44 ESTNewsTekla Life Sciences cuts dividend by 2%N/A
2021-09-22 17:50 ESTNewsTekla Life Sciences Investors Rides Biotechnology Wave, Offers Growth With Steady IncomeN/A
2021-08-26 06:12 ESTDividendA dividend of $0.43 has been announced on Aug 17, 2021. It will be paid Sep 30, 2021 with an ex-dividend date of Aug 26, 2021.Neutral
2021-07-22 16:19 ESTNewsEvaluating Closed-End Funds: HQL Is Another Fine Pick In A Hot SectorN/A
2021-05-27 06:17 ESTDividendA dividend of $0.41 has been announced on May 18, 2021. It will be paid Jun 30, 2021 with an ex-dividend date of May 27, 2021.Neutral
2021-02-25 05:18 ESTDividendA dividend of $0.43 has been announced on Feb 17, 2021. It will be paid Mar 31, 2021 with an ex-dividend date of Feb 25, 2021.Neutral
2021-02-16 21:53 ESTNewsTekla Life Sciences declares $0.43 dividendN/A
2021-01-09 17:53 ESTNewsTekla Life Sciences Investors: 8% Yield, 7% DiscountN/A
2020-12-30 05:16 ESTDividendA dividend of $0.02 has been announced on Dec 21, 2020. It will be paid Jan 6, 2021 with an ex-dividend date of Dec 30, 2020.Neutral
2020-12-21 20:50 ESTNewsTekla Life Sciences declares $0.02 special dividendN/A
2020-12-07 23:02 ESTFinancialsCompany financials have been released.Neutral
2020-12-04 19:00 ESTFinancialsCompany financials have been released.Neutral
2020-11-27 00:25 ESTFinancialsCompany financials have been released.Neutral
2020-11-25 05:12 ESTDividendA dividend of $0.4 has been announced on Nov 16, 2020. It will be paid Dec 31, 2020 with an ex-dividend date of Nov 25, 2020.Neutral
2020-11-18 04:28 ESTNewsTekla Life Sciences declares $0.40 dividendN/A
2020-11-07 19:31 ESTFinancialsCompany financials have been released.Neutral
2020-10-26 17:42 ESTInsider TradeDANIEL R OMSTEAD has directly acquired 6,175 shares and currently holds 131,836 shares.Buy
2020-10-21 19:59 ESTInsider TradeDANIEL R OMSTEAD has directly acquired 5,950 shares and currently holds 125,661 shares.Buy
2020-10-08 20:39 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 16:22 ESTFinancialsCompany financials have been released.Neutral
2020-09-23 16:14 ESTInsider TradeJeffrey Allen Bailey has directly acquired 580 shares and currently holds 580 shares.Buy
2020-09-17 09:01 ESTFinancialsCompany financials have been released.Neutral
2020-08-31 14:55 ESTFinancialsCompany financials have been released.Neutral
2020-08-27 06:09 ESTDividendA dividend of $0 has been announced on Aug 17, 2020. It will be paid Sep 30, 2020 with an ex-dividend date of Aug 27, 2020.Neutral
2020-08-27 06:09 ESTDividendA dividend of $0.41 has been announced on Aug 17, 2020. It will be paid Sep 30, 2020 with an ex-dividend date of Aug 27, 2020.Neutral
2020-08-17 23:29 ESTNewsTekla Life Sciences increases dividend by ~20%N/A
2020-08-14 12:27 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 16:07 ESTFinancialsCompany financials have been released.Neutral

About Tekla Life Sciences Investors (HQL):

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

HQL Quotes by TradingView

See Advanced Chart

General

  • Name Tekla Life Sciences Investors
  • Symbol HQL
  • Type Common Stock
  • Exchange NYSE
  • Currency USD
  • Country USA
  • SectorFinancial Services
  • IndustryAsset Management
  • Fiscal Year EndSeptember
  • IPO Date1992-05-04
  • Web URLhttp://www.teklacap.com/hql.html
View More

Valuation

  • Trailing PE 3.92
  • Price/Sales (Trailing 12 Mt.) 3.99
  • Price/Book (Most Recent Quarter) 1.02
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Profit Margin 3628%
  • Operating Margin -62%
  • Return on Equity 28%
  • Revenue 3.39 million
  • Earnings Per Share $5.15
  • Revenue Per Share $0.14
  • Gross Profit 3.39 million
  • Quarterly Earnings Growth -7.8%
View More

ESG Rating

  • Rating Date 2019-01-01
  • ESG Score 31
  • Environment Score 5.81
  • Social Score 16.4
  • Governance Score 11.61
  • Controversy Level 0
View More

Highlights

  • Market Capitalization 482.2 million
  • Book Value Per Share $20.25
View More

Share Statistics

  • Shares Outstanding 23.88 million
  • % Held by Insiders <1%
  • % Held by Institutions 20.21%
  • Shares Short 115655
  • Shares Short Prior Month 8497
  • Short Ratio 1.42
View More

Technicals

  • Beta 0.98
  • 52 Week High $21.88
  • 52 Week Low $11.14
  • 50 Day Moving Average 20.93
  • 200 Day Moving Average 19.14
View More

Dividends

  • Forward Annual Dividend Rate $1.72
  • Forward Annual Dividend Yield 8.34%
  • Payout Ratio 32%
  • Dividend Date 2018-12-31
  • ExDividend Date 2021-02-25
  • Dividend Per Share $1.47
  • Dividend Yield 9.88%
View More

Tekla Life Sciences Investors (HQL) Dividend Calendar:

Tekla Life Sciences Investors pays an annual dividend of $1.72 per share, with a dividend yield of 9.88%.
HQL's last dividend payment was made to shareholders on December 31, 2018.
Tekla Life Sciences Investors pays out 32% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Tekla Life Sciences Investors (HQL) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-06-302020-09-30$N/A$1.94$0.00
2020-03-312020-06-30$N/A$1.94$0.00
2019-12-312020-03-31$N/A$0.64$0.00
2019-09-302019-12-31$657010$0.64$0.00
2019-06-302019-09-30$657010-$0.68$0.00
2019-03-312019-06-30$563283-$0.68$0.00
2018-12-312019-03-31$563283-$0.86$0.00
2018-09-302018-12-31$494381-$0.86$0.00
2018-06-302018-09-30$494381$1.08$0.00
2018-03-312018-06-30$498531$1.08$0.00
2017-12-312018-03-31$498531-$0.45$0.00
2017-09-302017-12-31$1.24 million-$0.45$0.00
2017-06-302017-09-30$445744$0.97$0.00
2017-03-312017-06-30$N/A$0.97$0.00
2016-12-312017-03-31$N/A$0.63$0.00
2016-09-302016-12-31$1.44 million$0.63$0.00
2016-06-302016-09-30$N/A$1.38$0.00
2016-03-312016-06-30$N/A$1.38$0.00
2015-12-312016-03-31$N/A-$1.72$0.00
2015-09-302015-12-31$1.32 million-$1.72$0.00
2015-06-302015-09-30$N/A-$1.28$0.00
2015-03-312015-06-30$N/A-$1.28$0.00
2014-12-312015-03-31$N/A$2.36$0.00
2014-09-302014-12-31$876788$2.36$0.00
2014-06-302014-09-30$N/A$1.41$0.00
2014-03-312014-06-30$N/A$1.41$0.00
2013-12-312014-03-31$N/A$1.16$0.00
2013-09-302013-12-31$N/A$1.16$0.00
2013-06-302013-09-30$N/A$1.96$0.00
2013-03-312013-06-30$N/A$1.96$0.00
2012-12-312013-03-31$N/A$0.88$0.00
2012-09-302012-12-31$N/A$0.88$0.00
2012-06-302012-09-30$N/A$0.80$0.00
2012-03-312012-06-30$N/A$0.80$0.00
2011-12-312012-03-31$N/A$1.92$0.00
2011-09-302011-12-31$N/A$1.92$0.00
2011-06-302011-09-30$N/A-$0.19$0.00
2011-03-312011-06-30$N/A-$0.19$0.00
2010-12-312011-03-31$N/A$0.97$0.00
2010-09-302010-12-31$N/A$0.97$0.00

Tekla Life Sciences Investors (HQL) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Tekla Life Sciences Investors (HQL) Chart:

HQL chart by TradingView

Tekla Life Sciences Investors (HQL) News:

Below you will find a list of latest news for Tekla Life Sciences Investors (HQL) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Tekla Life Sciences Investors (HQL) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest HQL Trades:

Date Shares Price
Jun 13, 2022 4:16 PM EST100$13.19
Jun 13, 2022 5:29 PM EST100$13.23
Jun 13, 2022 5:29 PM EST100$13.23
Jun 13, 2022 6:07 PM EST100$13.29
Jun 13, 2022 6:07 PM EST100$13.27

Tekla Life Sciences Investors (HQL) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2017-06-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/884121/000110465917040117/0001104659-17-040117-index.htm
2017-06-19POS EXPost-effective amendment adding exhibits to registration statement [Rule 462(d)]https://www.sec.gov/Archives/edgar/data/884121/000110465917040137/0001104659-17-040137-index.htm
2017-07-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/884121/000110465917045485/0001104659-17-045485-index.htm
2017-07-2740-17GFidelity Bond [Rule 17G-1(g)]https://www.sec.gov/Archives/edgar/data/884121/000110465917047330/0001104659-17-047330-index.htm
2017-08-25N-QQuarterly Schedule of portfolio holdings of management investment companieshttps://www.sec.gov/Archives/edgar/data/884121/000110465917053653/0001104659-17-053653-index.htm
2017-08-30N-PXAnnual Report of proxy voting record of management investment companieshttps://www.sec.gov/Archives/edgar/data/884121/000110465917054431/0001104659-17-054431-index.htm
2017-12-05N-CSRCertified Shareholder Reporthttps://www.sec.gov/Archives/edgar/data/884121/000110465917071866/0001104659-17-071866-index.htm
2018-02-23N-QQuarterly Schedule of portfolio holdings of management investment companieshttps://www.sec.gov/Archives/edgar/data/884121/000110465918011670/0001104659-18-011670-index.htm
2018-04-18POS EXPost-effective amendment adding exhibits to registration statement [Rule 462(d)]https://www.sec.gov/Archives/edgar/data/884121/000110465918024689/0001104659-18-024689-index.htm
2018-04-18DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/884121/000110465918024806/0001104659-18-024806-index.htm
2018-04-25DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/884121/000110465918026537/0001104659-18-026537-index.htm
2018-06-01N-CSRSCertified Shareholder Report, Semi-Annualhttps://www.sec.gov/Archives/edgar/data/884121/000110465918037523/0001104659-18-037523-index.htm
2018-07-2740-17GFidelity Bond [Rule 17G-1(g)]https://www.sec.gov/Archives/edgar/data/884121/000110465918047582/0001104659-18-047582-index.htm
2018-08-20N-PXAnnual Report of proxy voting record of management investment companieshttps://www.sec.gov/Archives/edgar/data/884121/000110465918052797/0001104659-18-052797-index.htm
2018-08-28N-QQuarterly Schedule of portfolio holdings of management investment companieshttps://www.sec.gov/Archives/edgar/data/884121/000110465918053894/0001104659-18-053894-index.htm
2018-12-04N-CSRCertified Shareholder Reporthttps://www.sec.gov/Archives/edgar/data/884121/000110465918071295/0001104659-18-071295-index.htm
2018-12-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/884121/000110465918073771/0001104659-18-073771-index.htm
2019-02-26N-QQuarterly Schedule of portfolio holdings of management investment companieshttps://www.sec.gov/Archives/edgar/data/884121/000110465919010644/0001104659-19-010644-index.htm
2019-03-12POS EXPost-effective amendment adding exhibits to registration statement [Rule 462(d)]https://www.sec.gov/Archives/edgar/data/884121/000110465919014168/0001104659-19-014168-index.htm
2019-04-15DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/884121/000110465919021281/0001104659-19-021281-index.htm
2019-04-15DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/884121/000110465919021314/0001104659-19-021314-index.htm
2019-06-05N-CSRSCertified Shareholder Report, Semi-Annualhttps://www.sec.gov/Archives/edgar/data/884121/000110465919033995/0001104659-19-033995-index.htm
2019-06-20POS EXPost-effective amendment adding exhibits to registration statement [Rule 462(d)]https://www.sec.gov/Archives/edgar/data/884121/000110465919036644/0001104659-19-036644-index.htm
2019-08-1540-17GFidelity Bond [Rule 17G-1(g)]https://www.sec.gov/Archives/edgar/data/884121/000110465919046051/0001104659-19-046051-index.htm
2019-08-15N-PXAnnual Report of proxy voting record of management investment companieshttps://www.sec.gov/Archives/edgar/data/884121/000110465919046053/0001104659-19-046053-index.htm
2019-12-05N-CSRCertified Shareholder Reporthttps://www.sec.gov/Archives/edgar/data/884121/000110465919070186/0001104659-19-070186-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/884121/000110465920034866/0001104659-20-034866-index.htm
2020-04-14DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/884121/000110465920046205/0001104659-20-046205-index.htm
2020-05-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/884121/000110465920058473/0001104659-20-058473-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/884121/000110465920065199/0001104659-20-065199-index.htm
2020-06-05N-CSRSCertified Shareholder Report, Semi-Annualhttps://www.sec.gov/Archives/edgar/data/884121/000110465920070287/0001104659-20-070287-index.htm
2020-08-0640-17GFidelity Bond [Rule 17G-1(g)]https://www.sec.gov/Archives/edgar/data/884121/000110465920091251/0001104659-20-091251-index.htm
2020-08-17N-PXAnnual Report of proxy voting record of management investment companieshttps://www.sec.gov/Archives/edgar/data/884121/000110465920095898/0001104659-20-095898-index.htm
2020-08-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/884121/000110465920100107/0001104659-20-100107-index.htm
2020-09-10POS EXPost-effective amendment adding exhibits to registration statement [Rule 462(d)]https://www.sec.gov/Archives/edgar/data/884121/000110465920103794/0001104659-20-103794-index.htm
2020-09-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/884121/000110465920107789/0001104659-20-107789-index.htm
2020-10-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/884121/000110465920116861/0001104659-20-116861-index.htm
2020-10-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/884121/000110465920118221/0001104659-20-118221-index.htm
2017-11-27NSAR-BAnnual report for management companieshttps://www.sec.gov/Archives/edgar/data/884121/000141036817001710/0001410368-17-001710-index.htm
2018-05-25NSAR-ASemi-annual report for management companieshttps://www.sec.gov/Archives/edgar/data/884121/000141036818000796/0001410368-18-000796-index.htm
2019-01-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/884121/000144554619000483/0001445546-19-000483-index.htm
2019-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/884121/000144554619002968/0001445546-19-002968-index.htm
2020-02-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/884121/000144554620000619/0001445546-20-000619-index.htm
2018-01-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/884121/000172856418000002/0001728564-18-000002-index.htm
2018-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/884121/000172856418000006/0001728564-18-000006-index.htm
2018-12-13N-CENAnnual Report for Registered Investment Companieshttps://www.sec.gov/Archives/edgar/data/884121/000175272418002635/0001752724-18-002635-index.htm
2019-08-29NPORT-EXPortfolio Holdings Exhibit to Form N-PORThttps://www.sec.gov/Archives/edgar/data/884121/000175272419115617/0001752724-19-115617-index.htm
2019-11-15NPORT-PMonthly Portfolio Investments Report on Form N-PORT (Public)https://www.sec.gov/Archives/edgar/data/884121/000175272419163927/0001752724-19-163927-index.htm
2019-12-12N-CENAnnual Report for Registered Investment Companieshttps://www.sec.gov/Archives/edgar/data/884121/000175272419188841/0001752724-19-188841-index.htm
2020-02-27NPORT-PMonthly Portfolio Investments Report on Form N-PORT (Public)https://www.sec.gov/Archives/edgar/data/884121/000175272420040416/0001752724-20-040416-index.htm
2020-05-28NPORT-PMonthly Portfolio Investments Report on Form N-PORT (Public)https://www.sec.gov/Archives/edgar/data/884121/000175272420108408/0001752724-20-108408-index.htm
2020-08-25NPORT-PMonthly Portfolio Investments Report on Form N-PORT (Public)https://www.sec.gov/Archives/edgar/data/884121/000175272420169816/0001752724-20-169816-index.htm

Tekla Life Sciences Investors (HQL) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tekla Life Sciences Investors (HQL). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: < 1%
Institutional Ownership: 2021%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-03-17DANIEL R OMSTEADPresidentBuy8,300.0013.27110,106.97105,813.88https://www.sec.gov/Archives/edgar/data/884121/000110465920034866/0001104659-20-034866-index.htm
2020-05-21DANIEL R OMSTEADPresidentBuy5,950.0017.74105,556.57114,820.99https://www.sec.gov/Archives/edgar/data/884121/000110465920065199/0001104659-20-065199-index.htm
2020-10-21DANIEL R OMSTEADPresidentBuy5,950.0017.75105,605.96125,660.80https://www.sec.gov/Archives/edgar/data/884121/000110465920116861/0001104659-20-116861-index.htm
2018-01-25Thomas M KentDirectorBuy1,300.0021.0427,347.971,300.00https://www.sec.gov/Archives/edgar/data/884121/000172856418000006/0001728564-18-000006-index.htm
2020-10-26DANIEL R OMSTEADPresidentBuy6,175.0017.52108,203.91131,835.80https://www.sec.gov/Archives/edgar/data/884121/000110465920118221/0001104659-20-118221-index.htm
2020-09-22Jeffrey Allen BaileyDirectorBuy580.0017.2810,022.40580.00https://www.sec.gov/Archives/edgar/data/884121/000110465920107789/0001104659-20-107789-index.htm